Close Menu

layoffs

The Broad Institute confirmed that it is laying off 27 employees as the National Institutes of Health stopped funding for a program, and the institute separately decided to refocus its therapeutic development efforts.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific recorded about $55.6 million in restructuring charges related to the termination of employees during 2013, the company said in its Form 10-K on Thursday.

NEW YORK (GenomeWeb News) – PerkinElmer reduced its headcount by 74 employees in the fourth quarter of 2013, bringing the total headcount reduction during the year to 430, it disclosed in its Form 10K filed with the US Securities and Exchange Commission on Tuesday.

NEW YORK (GenomeWeb News) – PerkinElmer reduced its headcount by 30 employees in the third quarter, the company said in a regulatory document this week.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific spent about $9.7 million in costs related to severance of employees during the third quarter, the company said in its Form 10-Q filed on Friday.

NEW YORK (GenomeWeb News) – Roche is shuttering its 454 Life Sciences sequencing operations and laying off about 100 employees, the company confirmed today.

NEW YORK (GenomeWeb News) – Norwegian biomarker diagnostics firm DiaGenic today announced the initiation of a cost reduction program, which includes the elimination of an undisclosed number of jobs.

NEW YORK (GenomeWeb News) – Sequenom said in a regulatory filing after the close of the market on Monday that it is reducing its workforce by about 75 employees as part of a reorganization.

NEW YORK (GenomeWeb News) – Mayo Clinic in Florida said today that it has received a $5 million private donation to help fund the launch and operations of a new clinical center in Jacksonville that will use genomic technologies to tailor treatments to individual patients.

NEW YORK (GenomeWeb News) – GeneNews today announced a restructuring of the company that includes the resignation of its President and COO Gailina Liew and a reduction in headcount of about 60 percent of its staff.

Pages

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.